Edition:
United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

10.75USD
17 Jun 2019
Change (% chg)

-- (--)
Prev Close
$10.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
176,337
52-wk High
$11.33
52-wk Low
$5.76

Malik, Fady 

Dr. Fady I. Malik, M.D., Ph.D., is Executive Vice President - Research and Development of the Company. Dr. Malik served as our Senior Vice President of Research and Development from August 2014 to November 2015. Dr. Malik served as our Senior Vice President of Research and Early Development from June 2012 to August 2014. He has been with Cytokinetics since our inception in 1998, serving in a variety of roles, including Vice President, Biology from March 2008 to June 2012, all focused towards building our cardiovascular and muscle programs. Since 2000, Dr. Malik has held an appointment in the Cardiology Division of the University of California, San Francisco, where he is currently a Clinical Professor and an Attending Interventional Cardiologist at the San Francisco Veterans Administration Medical Center. Dr. Malik received a B.S. from the University of California at Berkeley, a Ph.D. from the University of California at San Francisco and his M.D. from the University of California at San Francisco.

Basic Compensation

Total Annual Compensation, USD 635,937
Restricted Stock Award, USD 215,793
Long-Term Incentive Plans, USD --
All Other, USD 368,205
Fiscal Year Total, USD 1,219,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 6,666 21,568.00
Name Fiscal Year Total

Leonard Patrick Gage

291,926

Robert Blum

2,867,840

Ching Jaw

1,099,890

Fady Malik

1,219,940

David Cragg

388,209

Robert Wong

--
As Of  31 Dec 2017